HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David V Gold Selected Research

colon-specific antigen

6/2005Identification of a Mu-9 (anti-colon-specific antigen-p)-reactive peptide having homology to CA125 (MUC16).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David V Gold Research Topics

Disease

18Neoplasms (Cancer)
02/2015 - 01/2002
11Pancreatic Neoplasms (Pancreatic Cancer)
02/2015 - 01/2002
8Adenocarcinoma
02/2015 - 12/2007
3Lymphoma (Lymphomas)
06/2013 - 10/2004
2Chronic Pancreatitis
02/2014 - 11/2010
1Disease Progression
02/2015
1Hepatocellular Carcinoma (Hepatoma)
06/2013
1Pancreatic Diseases (Pancreatic Disease)
02/2013
1Neoplasm Metastasis (Metastasis)
01/2013
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2013
1Hodgkin Disease (Hodgkin's Disease)
01/2013
1Pancreatic Ductal Carcinoma
11/2012
1Glioblastoma (Glioblastoma Multiforme)
07/2012
1Smallpox (Variola)
06/2012
1Thrombocytopenia (Thrombopenia)
06/2011
1Neutropenia
06/2011
1Pancreatitis
12/2007
1Ovarian Neoplasms (Ovarian Cancer)
06/2005
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
06/2005
1Multiple Myeloma
10/2004

Drug/Important Bio-Agent (IBA)

10Monoclonal AntibodiesIBA
02/2015 - 09/2003
7GemcitabineFDA Link
11/2012 - 01/2002
5clivatuzumabIBA
02/2015 - 04/2004
5Peptides (Polypeptides)IBA
12/2009 - 05/2004
4Biomarkers (Surrogate Marker)IBA
02/2015 - 12/2007
4MucinsIBA
02/2015 - 12/2009
4AntigensIBA
02/2014 - 06/2005
3EpitopesIBA
02/2015 - 12/2007
3Immunoglobulin G (IgG)IBA
06/2013 - 04/2004
3Proteins (Proteins, Gene)FDA Link
01/2013 - 10/2004
3CeramidesIBA
06/2009 - 11/2004
2milatuzumabIBA
06/2013 - 01/2013
2EnzymesIBA
02/2013 - 02/2006
2DNA (Deoxyribonucleic Acid)IBA
01/2013 - 07/2012
2Pharmaceutical PreparationsIBA
06/2011 - 04/2004
2HaptensIBA
12/2009 - 06/2008
2SphingomyelinsIBA
06/2009 - 11/2004
1Small Interfering RNA (siRNA)IBA
02/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2013
1Irinotecan (Camptosar)FDA LinkGeneric
06/2013
1CA-19-9 Antigen (CA 19-9 Antigen)IBA
02/2013
1GW 532IBA
01/2013
1Viral VaccinesIBA
06/2012
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
06/2011
1Glycoproteins (Glycoprotein)IBA
06/2011
1Glycine (Aminoacetic Acid)FDA LinkGeneric
12/2009
1Histamine (Histamine Dihydrochloride)FDA Link
12/2009
1Therapeutic UsesIBA
12/2009
1AcidsIBA
12/2009
1SphingolipidsIBA
02/2006
1colon-specific antigenIBA
06/2005
1LipidsIBA
11/2004
1Messenger RNA (mRNA)IBA
10/2004
1ThymidineIBA
10/2004
1Radioisotopes (Radionuclides)IBA
10/2004
1Rituximab (Mabthera)FDA Link
05/2004
1Inosine Monophosphate (IMP)IBA
05/2004
1Mucin-1 (CA 15-3 Antigen)IBA
09/2003
1DeoxycytidineIBA
01/2002

Therapy/Procedure

7Therapeutics
11/2013 - 04/2004
7Radioimmunotherapy
11/2012 - 01/2002
2Drug Therapy (Chemotherapy)
11/2004 - 09/2003
1Immunotherapy
01/2013
1Pancreaticoduodenectomy
01/2013
1Transplantation
07/2012
1Intravenous Injections
01/2002
1Intraperitoneal Injections
01/2002